Trust CO Of The South Tg Therapeutics, Inc. Transaction History
Trust CO Of The South
- $479 Billion
- Q1 2025
A detailed history of Trust CO Of The South transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Trust CO Of The South holds 10,600 shares of TGTX stock, worth $422,516. This represents 0.09% of its overall portfolio holdings.
Number of Shares
10,600
Previous 10,600
-0.0%
Holding current value
$422,516
Previous $319 Million
31.0%
% of portfolio
0.09%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
372Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$622 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$454 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$367 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$127 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$111 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.79B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...